TY - JOUR
T1 - Severe COVID-19 Is Associated With an Altered Upper Respiratory Tract Microbiome
AU - Shilts, Meghan H.
AU - Rosas-Salazar, Christian
AU - Strickland, Britton A.
AU - Kimura, Kyle S.
AU - Asad, Mohammad
AU - Sehanobish, Esha
AU - Freeman, Michael H.
AU - Wessinger, Bronson C.
AU - Gupta, Veerain
AU - Brown, Hunter M.
AU - Boone, Helen H.
AU - Patel, Viraj
AU - Barbi, Mali
AU - Bottalico, Danielle
AU - O’Neill, Meaghan
AU - Akbar, Nadeem
AU - Rajagopala, Seesandra V.
AU - Mallal, Simon
AU - Phillips, Elizabeth
AU - Turner, Justin H.
AU - Jerschow, Elina
AU - Das, Suman R.
N1 - Funding Information:
This work was supported by funds from the National Institute of Allergy and Infectious Diseases (under award numbers R21AI142321-02S1, R21AI142321, R21AI154016, and R21AI149262); Centers for Disease Control and Prevention (CDC) 75D3012110094; the National Heart, Lung, and Blood Institute (under award numbers K23HL148638 and R01HL146401); and the Vanderbilt Technologies for Advanced Genomics Core (grant support from the National Institutes of Health under award numbers UL1RR024975, P30CA68485, P30EY08126, and G20RR030956). This research was also supported by NIH/National Center for Advancing
Publisher Copyright:
Copyright © 2022 Shilts, Rosas-Salazar, Strickland, Kimura, Asad, Sehanobish, Freeman, Wessinger, Gupta, Brown, Boone, Patel, Barbi, Bottalico, O’Neill, Akbar, Rajagopala, Mallal, Phillips, Turner, Jerschow and Das.
PY - 2022/1/24
Y1 - 2022/1/24
N2 - Background: The upper respiratory tract (URT) is the portal of entry of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), and SARS-CoV-2 likely interacts with the URT microbiome. However, understanding of the associations between the URT microbiome and the severity of coronavirus disease 2019 (COVID-19) is still limited. Objective: Our primary objective was to identify URT microbiome signature/s that consistently changed over a spectrum of COVID-19 severity. Methods: Using data from 103 adult participants from two cities in the United States, we compared the bacterial load and the URT microbiome between five groups: 20 asymptomatic SARS-CoV-2-negative participants, 27 participants with mild COVID-19, 28 participants with moderate COVID-19, 15 hospitalized patients with severe COVID-19, and 13 hospitalized patients in the ICU with very severe COVID-19. Results: URT bacterial load, bacterial richness, and within-group microbiome composition dissimilarity consistently increased as COVID-19 severity increased, while the relative abundance of an amplicon sequence variant (ASV), Corynebacterium_unclassified.ASV0002, consistently decreased as COVID-19 severity increased. Conclusions: We observed that the URT microbiome composition significantly changed as COVID-19 severity increased. The URT microbiome could potentially predict which patients may be more likely to progress to severe disease or be modified to decrease severity. However, further research in additional longitudinal cohorts is needed to better understand how the microbiome affects COVID-19 severity.
AB - Background: The upper respiratory tract (URT) is the portal of entry of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), and SARS-CoV-2 likely interacts with the URT microbiome. However, understanding of the associations between the URT microbiome and the severity of coronavirus disease 2019 (COVID-19) is still limited. Objective: Our primary objective was to identify URT microbiome signature/s that consistently changed over a spectrum of COVID-19 severity. Methods: Using data from 103 adult participants from two cities in the United States, we compared the bacterial load and the URT microbiome between five groups: 20 asymptomatic SARS-CoV-2-negative participants, 27 participants with mild COVID-19, 28 participants with moderate COVID-19, 15 hospitalized patients with severe COVID-19, and 13 hospitalized patients in the ICU with very severe COVID-19. Results: URT bacterial load, bacterial richness, and within-group microbiome composition dissimilarity consistently increased as COVID-19 severity increased, while the relative abundance of an amplicon sequence variant (ASV), Corynebacterium_unclassified.ASV0002, consistently decreased as COVID-19 severity increased. Conclusions: We observed that the URT microbiome composition significantly changed as COVID-19 severity increased. The URT microbiome could potentially predict which patients may be more likely to progress to severe disease or be modified to decrease severity. However, further research in additional longitudinal cohorts is needed to better understand how the microbiome affects COVID-19 severity.
KW - COVID-19
KW - SARS-CoV-2
KW - microbiome
KW - mild
KW - moderate
KW - severe COVID-19 outcomes
KW - upper respiratory tract
UR - http://www.scopus.com/inward/record.url?scp=85124206095&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85124206095&partnerID=8YFLogxK
U2 - 10.3389/fcimb.2021.781968
DO - 10.3389/fcimb.2021.781968
M3 - Article
C2 - 35141167
AN - SCOPUS:85124206095
SN - 2235-2988
VL - 11
JO - Frontiers in Cellular and Infection Microbiology
JF - Frontiers in Cellular and Infection Microbiology
M1 - 781968
ER -